Skip to content
  • Who We Are
    • CPA Team
    • Alliances
    • Member Associations
    • Partners
  • Strategy
    • Our Impact
  • Our Work
    • AMR
    • COVID-19
    • CPD
    • PharmAid
  • Join
    • Support Us
    • Join The Team
  • Latest
    • Events
    • News
    • Blog
    • Publications
  • Contact
Menu
  • Who We Are
    • CPA Team
    • Alliances
    • Member Associations
    • Partners
  • Strategy
    • Our Impact
  • Our Work
    • AMR
    • COVID-19
    • CPD
    • PharmAid
  • Join
    • Support Us
    • Join The Team
  • Latest
    • Events
    • News
    • Blog
    • Publications
  • Contact
linkedinCreated with Sketch. InstagramCreated with Sketch. FacebookCreated with Sketch. TwitterCreated with Sketch. Youtube

Commonwealth Civil Society Policy Forum 2022

Commonwealth Civil Society Policy Forum 2022

Commercial determinants of health: evidence, tools, dialogue and advocacy

Commercial determinants of health: evidence, tools, dialogue and advocacy

This year’s Civil Society Policy Forum was looking at how commercial events can determine health outcomes. As a community pharmacist I was interested to see how commercial decisions impact on health and how this can be countered. 

 

This is important to ensure civil society has the tools to ensure the best decisions are being taken for the best health outcomes. Commercial organisations’ first commitment is to their shareholders, not necessarily to public health. There is a need to understand and be aware of how this impacts on decision making.

 

After some opening remarks from HE Baroness Patricia Scotland and an introduction to the Forum by Anne Gallagher we got into the detailed discussion.

 

Firstly, we had Jenn Lacy-Nichols from the Melbourne School of Population Health presenting on her work which focuses on methods to monitor the political practices of corporations. 

 

She was presenting on the need to strengthen the evidence base on which we build our policies and strategies. Jenn gave an example of how the soft drinks industry sought to position itself as part of the solution to obesity and how this led to their involvement and input into government strategies fighting obesity. 

 

Secondly, Camila Maranha P. de Carvalho from the Fluminense Federal University of Brazil presented on how to prevent and manage conflicts of interest in nutritional programs. 

 

Camila works with others researching global ethics and how conflicts of interest can affect public health. She presented on how her work has demonstrated how conflicts of interest affected decisions on tobacco control and health promotion and how these same tactics are used today by other organisations.

 

Thirdly, we had Robin Ireland speaking about how commercial marketing has developed in sport over the last few decades and how this was not necessarily for the benefit of public health. He is the former Chief Executive of the Health Equalities Group charity based in Liverpool. 

 

Robin also discussed the need for developing partnerships and dialogue to help address the problem, though he was very aware conflicts of interest needed managing. In his presentation he discussed how commercial marketing and promotion in sport affect the public perception on current issues and what is good for our health. He went on to say academia and civil Society have a huge role to play in addressing these issues.

 

Finally, Shona Hilton from the University of Glasgow spoke on the theme of raising awareness and advocacy. Shona is Professor of Public health Policy at the University, and her focus was on the need to improve the timely translation of scientific knowledge into policy and practice. She discussed the influence of commercial industries and the media and how this affected public policy, not always for the better.

 

During the discussion, the role of academia and external/commercial finance was discussed and how this can be seen as a privatisation of public institutions and their research. This can lead to an influence on both what is researched and how it is used. 

 

It was also mentioned that public institutions such as universities having to balance their need to be open and transparent with commercial sensitivities. This was important in the context of research funding from government for the public benefit and the use of such research to produce, for example covid-19 vaccines, then pharma companies charging commercial rates for the final product.

 

As an outcome of the Forum, four draft recommendations were agreed by those in attendance.

 

Recommendation 1: strengthen the evidence base

Commonwealth Governments budget for country-specific, regional and global research to build the evidence-base to better document the impacts of Commercial Determinants of Health on their populations.

 

Recommendation 2: develop tools and capacity to address the Commercial Determinants of Health 

Commonwealth governments strengthen legislation and governance structures to minimize opportunities for commercial actors to influence policy development, and to support the participation of civil society in democratic policy making.

 

Recommendation 3: convene partnerships and dialogue

Commonwealth governments partner with civil society to identify and implement strategies that minimize the negative impacts of Commercial Determinants of Health and highlight strategies to foster health promoting commercial practices (while ensuring that the latter are not used to compensate for health harming practices).

 

Recommendation 4: raise awareness and advocacy

Commonwealth governments support independent monitoring and reporting mechanisms to share information about the impacts of Commercial Determinants of Health on peoples and society.

 

 

Finally, and as an overview, for pharmacy it is vitally important to be aware of how corporations and commercial entities are a key factor in determining the health of citizens.

The way we practice and how we are influenced is essential, if, as professionals we are to seek better health for our patients and customers. Governments set policy and strategy, but this is and has always been influenced by many actors with “skin in the game” and we need to ensure as pharmacists we play our full part.

Raymond Anderson

Raymond Anderson

Raymond is a Past President of the CPA. While President he helped restructure the organisation into what it is today. He is a community pharmacist for over 40 years and has supported the development of the profession to become more patient facing, using a pharmacist’s clinical skills for the benefit of patients. He is a strong advocate of good regulation and governance which is essential for the profession to reach its full potential across the commonwealth.

Get the latest

Events
News
Blog
Events

Launch of CPA-FIP Joint Webinar Series: AMS In Action

December 1, 2022

Recordings From The CPA-FIP Joint Webinar Series About The Webinars We are pleased share recordings from the webinars we hosted in partnership with The International

Launch of CPA-FIP Joint Webinar Series: AMS In Action

October 7, 2022

Launch of CPA-FIP Joint Webinar Series: AMS In Action About The Webinars We are pleased to announce that in partnership with The International Pharmaceutical Federation

Event: CHOGM Rwanda 2022

August 8, 2022

CHOGM Rwanda 2022  Leaders of Commonwealth countries meet every two years for the Commonwealth Heads of Government Meeting (CHOGM) The 2022  Commonwealth Heads of Government

The CPA and Novartis partner to support pharmacists

November 3, 2021

The Commonwealth Pharmacists Association (CPA) and Novartis partner to support pharmacists About The Partnership London, United Kingdom (8th November 2021). The Commonwealth Pharmacists Association (CPA) and

News

Join our expert panel of CwPAMS grant assessors

November 22, 2022

Join our expert panel of CwPAMS grant assessors The Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) is a health partnership programme funded by the UK aid

Meet The New CPA President, Vice President, Councillors, and Regionals Representatives

October 14, 2022

Meet The New CPA President, Vice President, Councillors, and Regionals Representatives Following the recent CPA elections, we are pleased to announce our new Councillors, President,

CwPAMS 2 (2022-2025) – Applications are now open

September 1, 2022

CwPAMS 2 Programme (2022 – 2025) Applications are open until the 15th of December 2022 The Tropical Health and Education Trust (THET) and the Commonwealth

The CPA Newsletter – Q2

July 7, 2022

Welcome to the roundup of our latest news. We hope you enjoy hearing about our latest work and activities.

Blog

Fighting Antimicrobial Resistance In Bangladesh: The Pharmacists’ Story

November 25, 2022

Fighting Antimicrobial Resistance In Bangladesh: The Pharmacists’ Story World Antimicrobial Awareness Week 2022 Antimicrobial resistance (AMR) is a rapidly growing health crisis with severe repercussions

Blog: CPA advocacy at the Commonwealth People’s Forum 2022

August 8, 2022

CPA advocacy at the Commonwealth People’s Forum (CHOGM 2022) The theme for CHOGM 2022 was ‘Delivering a Common Future: Connecting, Innovating, Transforming.’  In the second of

Blog: CPA raising the profile of Pharmacy at CHOGM 2022

August 8, 2022

CPA raising the profile of pharmacy at CHOGM 2022 The theme for CHOGM 2022 was ‘Delivering a Common Future: Connecting, Innovating, Transforming.’  In the first of

Blog: Sharing and learning about antimicrobial stewardship from eight African countries

July 11, 2022

Sharing and learning about antimicrobial stewardship from eight African countries    Outcomes from a CwPAMS Extension Sharing and Learning Event  On the 30th of June 2022,

Who we are

  • Alliances
  • Join Us
  • Contact Us
  • Alliances
  • Join Us
  • Contact Us

About us

  • Strategy
  • News
  • Blog
  • Strategy
  • News
  • Blog

Our work

  • AMR
  • COVID-19
  • CPD
  • PharmAid
  • AMR
  • COVID-19
  • CPD
  • PharmAid
© 2023 CPA
  • Privacy Notice
  • Terms & Conditions
  • Disclaimer
  • Privacy Notice
  • Terms & Conditions
  • Disclaimer

CIO Registered charity number: 1176132